Sign in for the best experience.
Everything we publish is designed to keep you up-to-date on the latest news, approaches, and ideas in chest medicine. From the most relevant research findings to the most significant clinical guidelines, these are the highly accredited resources you count on from CHEST.
Advertisement
Used throughout the world, our multidisciplinary guidelines help translate quality evidence into applicable recommendations that enrich patient care and improve health outcomes.
FEATURED GUIDELINE
Antithrombotic Therapy in COVID-19
This CHEST guideline contains 11 evidence-based recommendations to improve risk evaluation and assist in determining the course of treatment.
Respiratory Management of Patients With Neuromuscular Weakness
These recommendations cover guidelines for mouthpiece ventilation, transition to home mechanical ventilation, salivary secretion management, and airway clearance therapies in patients experiencing respiratory muscle weakness.
Access CHEST’s full collection of guidelines, expert panel reports, and consensus statements.
Guideline topics
Airway Disorders
Chest Infections
Clinical Pulmonary
Critical Care
Interstitial Lung Disease
Interventional Pulmonary
Pulmonary Vascular
Thoracic Oncology
The CHEST® journal portfolio features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine—pulmonary, critical care, and sleep medicine—and related disciplines. With a loyal readership base, the portfolio, including the journals CHEST, CHEST® Critical Care, and CHEST® Pulmonary, is one of the most highly regarded, and up-to-date sources of clinical knowledge in the field.
Mobile App-Based Mindfulness Intervention for Addressing Psychological Distress Among Survivors of Hospitalization for COVID-19 Infection
A study in CHEST® Critical Care examined if a self-directed mobile app-delivered mindfulness intervention could be feasibly and rapidly implemented within a clinical trials network to reduce distress symptoms among survivors of hospitalization due to COVID-19-related illness.
Urban-Rural Differences in Idiopathic Pulmonary Fibrosis-Related Mortality Rates in the United States
Patients with idiopathic pulmonary fibrosis (IPF) who live in remote areas are likely to experience worse outcomes due to limited access to interstitial lung disease specialty care. A recent journal CHEST® study aimed to assess IPF-related mortality rates and trends, stratified by urbanization in the United States.
COPD Exposed to Air Pollution: A Path to Understand and Protect a Susceptible Population
Long- and short-term exposures to higher levels of particulate-rich air pollution are associated with increased COPD exacerbation. A review published in the journal CHEST® summarizes the evidence for COPD as a phenotype that confers susceptibility for adverse health outcomes in the face of common air pollution.
See if you can answer this question based on a recent journal CHEST article.
Each month, the journal CHEST Editor in Chief Peter Mazzone, MD, MPH, FCCP, adds context and commentary to important articles featured in the new issue.
OPEN ACCESS JOURNALS | Submit your research to be published in our new journals. CHEST® CRITICAL CARE » | CHEST® PULMONARY »
Whatever your specialty, CHEST has a topic collection that you’ll be interested in. Uncover insights from key opinion leaders, find CME opportunities, and discover original research articles.
With the Bridging Specialties™: Timely Diagnosis for ILD initiative, we're defining a clearer clinician-guided approach to diagnosis for interstitial lung diseases like pulmonary fibrosis. Explore expert-based clinical resources that you can use in your practice.
LEARN MORE
Do you want to hear directly from your colleagues on the topics that matter most? Catch up on episodes that feature critical discussions with giants in the field and hear directly from authors featured in CHEST journal.
Originally aired: April 5, 2024
CHEST® journal Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key articles published in the April 2024 issue.
Originally aired: April 1, 2024
Elizabeth S. Munroe, MD, discusses the use of vasopressors in routine practice and potential associations between vasopressor initiation route and in-hospital mortality.
Sonia Graziano, PsyD, discusses how elexacaftor/tezacaftor/ivacaftor affects mental health, cognitive processing, neuropsychological side effects, GI symptoms, and health-related quality of life in people with cystic fibrosis.
Originally aired: March 1, 2024
In part six of a six-part podcast series, James K. Stoller, MD, MS, FCCP, discusses the importance of having a strategic plan to reach organizational goals.
Clinical advances, practice management updates, medical conference highlights—reading the CHEST Physician® publication is the easiest way to be in the know every month.